Mohs Surgery vs Radiation for Skin Cancer: Which Treatment Is Better?

Patients diagnosed with non-melanoma skin cancer are usually told they have options, and the two that come up most often are Mohs surgery and radiation therapy. Both are established, well-studied treatments for basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC), the two most common forms of skin cancer. Naturally, the first question I hear in clinic is some version of mohs vs radiation – which one cures it better?

Much depends on the tumor: its type, its location, and the way it behaves histologically. The patient’s age and general health weigh on the choice just as heavily. The sections that follow set out how each treatment works, whom it tends to suit, and where its limits lie in the mohs vs radiation comparison.

What Is Mohs Surgery?

Frederic Mohs worked out the basic idea in the 1930s. His early version took days and relied on chemical fixation; the technique we use now is finished in a single day with fresh-frozen tissue (1). Precision is what it is known for. Patients often want to know how does Mohs surgery work, and the answer lies in the sequence of the procedure itself.

The surgeon begins by removing the visible tumor along with a narrow margin of surrounding skin. That specimen is then divided and color-coded so that each edge can be traced back precisely to its position in the wound, after which the surgeon examines the complete margin under the microscope while the patient remains in the office. Clear all around, and the case is done. If cancer sits at one edge, the surgeon returns to that single mapped point and takes a little more, nothing else. Layer by layer, until the margins come back clean. Because the whole margin is examined while the patient is still in the chair, there is no guessing about whether the cancer is out, and the wound is usually repaired the same afternoon (1, 2).

When is Mohs surgery recommended? Selection follows the Appropriate Use Criteria (AUC) developed jointly by the American Academy of Dermatology and the Mohs surgery societies (3). The criteria weigh anatomic location, tumor features, and patient factors. So-called “Area H” – the central face, eyelids, nose, lips, ears, as well as the genitals, hands, and feet – almost always favors Mohs because tissue there is functionally and cosmetically precious (2, 3). Aggressive or poorly defined tumors, recurrent cancers, and cancers in immunosuppressed or transplant patients are also strong candidates (1, 3).

The main Mohs surgery benefits are high cure rates, maximal preservation of healthy skin, and immediate margin confirmation, all in a single visit under local anesthesia (2, 4). Mohs surgery recovery is generally straightforward. Discomfort in the first day or two is usually managed with acetaminophen and ibuprofen, and while some bruising and swelling may last around a week, most patients resume their normal routine shortly thereafter (4).

What Is Radiation Therapy for Skin Cancer?

Radiation therapy provides a way to treat skin cancer without an incision. In terms of how does radiation therapy work for skin cancer, focused beams of ionizing radiation damage the DNA inside the tumor cells, so that cells unable to repair themselves stop dividing and gradually die (5). The sessions themselves are painless and brief, though a full course is spread across many visits over several weeks (6).

When is radiation used for skin cancer? In practice, skin cancer radiation is most valuable for patients who cannot tolerate surgery or decline it – the very elderly, the frail, those on multiple blood thinners, or patients whose wounds heal poorly (6, 7). It is also useful when surgery would be disfiguring, and in the postoperative setting when margins cannot be fully cleared or when there is perineural (nerve) involvement (8). This mirrors current guidance: the American Society for Radiation Oncology recommends definitive radiation as primary treatment for patients who are not surgical candidates, and conditionally to preserve appearance and function (8).

Radiation Therapy vs Superficial Radiation Therapy

Not all skin cancer radiation treatment is the same. Conventional, or external-beam, radiation uses higher-energy beams that reach deeper tissues, which makes it the appropriate choice for larger, more advanced, or node-involved tumors (6). Superficial radiation therapy (SRT) works on a different scale. It uses low-energy kilovoltage X-rays – roughly 50 to 100 kVp – that penetrate only a short distance, so the dose concentrates in the skin and largely spares deeper structures (9). SRT is best suited to well-defined, superficial tumors, typically those less than about 2 mm deep and 2 cm across (7).

A more recent refinement, image-guided SRT, pairs the treatment with high-resolution dermal ultrasound (around 22 MHz) so the clinician can measure tumor depth and adjust the energy accordingly (9, 10). These modern X-Ray Radiation Therapy Systems have broadened the non-surgical options for selected patients. It is worth distinguishing SRT from a phototherapy device, which uses ultraviolet light to treat inflammatory conditions such as psoriasis rather than to destroy cancer.

Mohs Surgery vs Radiation: How to Decide

The decision of surgery or radiation for skin cancer comes down to a handful of practical factors.

Effectiveness. Mohs offers the highest cure rate of any skin cancer treatment – commonly cited between 97% and 99% for primary BCC and SCC – supported by 5- and 10-year follow-up data (2, 4). SRT also performs well in appropriate cases; reported local recurrence averages around 4.2% for BCC and 6.4% for SCC (7), and image-guided SRT series have reported local control above 99% in short-term follow-up (10, 11). One important caveat drives much of the professional debate: Mohs confirms cure histologically under the microscope, whereas radiation success is judged clinically or by imaging, which can miss disease hiding at the edges. Many SRT studies are also retrospective with relatively short follow-up, and a Journal of the American Academy of Dermatology analysis found SRT-treated cancers more likely to recur than those treated with Mohs (6, 4).

Cosmetic outcomes and recovery. Mohs leaves a surgical wound and scar but preserves the most tissue possible, which usually gives excellent long-term cosmesis on the face (2). Radiation avoids a wound entirely, though irradiated skin can change over the years – thinning, small visible vessels (telangiectasias), and pigment shifts may appear well after treatment ends (12).

Treatment duration. Mohs is normally completed in one day. A radiation course typically runs 15 to 30 sessions, several times weekly over several weeks (6, 13).

Patient and tumor factors. For facial lesions and cosmetically sensitive sites, Mohs is the usual first line (2, 3). For older or medically fragile patients, radiation can be the kinder path (7). Because radiated tissue is harder to operate on if the cancer returns, and because the field carries a small long-term risk of a new radiation-induced cancer, radiation is generally reserved for older patients rather than younger ones (12). Non-invasive imaging such as reflection confocal microscopy can help characterize lesions and monitor the skin over time, whichever treatment is chosen.

Whatever the tumor type, these decisions are individualized and belong in a shared conversation between patient and treating physician.

Benefits and Limitations of Mohs Surgery and Radiation Therapy

Benefits of Mohs Surgery

Mohs preserves healthy tissue, delivers the highest cure rates for appropriate tumors, and provides complete margin assessment with same-day results and reconstruction (1, 2, 4). Because it is finished in one visit, it is also cost-effective relative to a multi-week radiation course (13).

Limitations of Mohs Surgery

It is still surgery. It requires local anesthesia, creates a wound that needs repair, and carries a small risk of bleeding, infection, or scarring (4). It is not the right choice for every patient – those who genuinely cannot tolerate a procedure, or who refuse one, are better served by another approach.

Benefits of Radiation Therapy

Radiation is non-surgical, needs no cutting or anesthesia, and leaves no immediate wound, which makes it valuable for poor surgical candidates and for cancers in areas where surgery would be difficult (6, 7). It can treat cosmetically sensitive sites, plays a defined postoperative role, and image-guided approaches can address more than one lesion in a session (8, 10).

Limitations of Radiation Therapy

There is no histologic proof of clearance, long-term cure rates are generally lower than Mohs for many scenarios, and the course demands many visits (4, 6). Side effects range from acute radiation dermatitis to late tissue changes appearing years later, and the field carries a small secondary-cancer risk (12). Cost is another consideration: a 2026 Medicare analysis found image-guided SRT ran substantially more expensive than a representative Mohs case – on the order of 217% higher for a 12-session course and up to roughly 559% higher for longer courses – alongside a sharp rise in utilization that has prompted appropriate-use scrutiny (14).

Key Differences at a Glance

Neither treatment is universally better. Mohs is the benchmark for cure and margin control, while radiation remains an important, guideline-supported option for well-chosen patients. Guidelines from the NCCN, AAD, and ASTRO converge on the same principle: surgery is the preferred curative treatment for most BCC and SCC, with definitive radiation reserved primarily for those who cannot undergo or decline it (3, 8, 15). Modern superficial X-ray radiation therapy systems have genuinely expanded the non-surgical menu for selected skin cancer patients – a welcome development, provided the indication is right.